» Articles » PMID: 35647200

LncRNA DLEU1 Modulates Proliferation, Inflammation, and Extracellular Matrix Degradation of Chondrocytes Through Regulating MiR-671-5p

Overview
Journal J Immunol Res
Publisher Wiley
Date 2022 Jun 1
PMID 35647200
Authors
Affiliations
Soon will be listed here.
Abstract

Long noncoding RNAs (lncRNAs) have been shown to be involved in the development of osteoarthritis. However, the expression, function, and mechanism of DLEU1 in OA development remain largely unclear. The present reference demonstrates that DLEU1 is overexpressed in OA specimens compared to control cartilages. Inflammatory cytokines IL-1, TNF-, and IL-6 induce DLEU1 expression in chondrocytes. Ectopic expression of DLEU1 induces chondrocyte proliferation, degradation of ECM, and inflammation mediators such as IL-6, IL-8, and TNF- secretion. Moreover, we demonstrated that DLEU1 targets miR-671-5p expression in chondrocytes. Overexpression of DLEU1 suppresses miR-671-5p expression in chondrocytes. The expression of miR-671-5p is decreased in OA specimens compared to control cartilages. There is a negative correlation between the expression of miR-671-5p and DLEU1 in OA specimens. Inflammatory mediators IL-1, TNF-, and IL-6 suppress miR-671-5p expression in OA specimens. Elevated expression of miR-671-5p suppresses chondrocyte proliferation, degradation of ECM, and secretion of inflammation mediators. DLEU1 overexpression promotes chondrocytes proliferation, degradation of ECM, and secretion of inflammation mediators via regulating miR-671-5p. These results suggested that DLEU1 acts as one destructive role in OA development via regulating miR-671-5p.

Citing Articles

LncRNA DLEU1 contributes to the progression of septic myocardial dysfunction by targeting miR-381-3p.

Tian T, Zhang N, Hu G, Lu R, Liu J Cent Eur J Immunol. 2024; 49(3):227-237.

PMID: 39720275 PMC: 11664811. DOI: 10.5114/ceji.2024.144199.


Roles of long noncoding RNAs in human inflammatory diseases.

Zhang Y, Liu H, Niu M, Wang Y, Xu R, Guo Y Cell Death Discov. 2024; 10(1):235.

PMID: 38750059 PMC: 11096177. DOI: 10.1038/s41420-024-02002-6.


Long Non-coding RNA DLEU1 Promotes Progression of Osteoarthritis via miR-492/ Axis.

Ni C, Zhang W, Qiu S, Cheng H, Ma C Curr Pharm Biotechnol. 2024; 25(16):2166-2181.

PMID: 38321900 DOI: 10.2174/0113892010275579240116061104.


Integrated Analysis of Non-Coding RNA and mRNA Expression Profiles in Exosomes from Lung Tissue with Sepsis-Induced Acute Lung Injury.

Deng W, Lu Y, Hu P, Zhang Q, Li S, Yang D J Inflamm Res. 2023; 16:3879-3895.

PMID: 37674532 PMC: 10478974. DOI: 10.2147/JIR.S419491.


LncRNA DLEU1 promotes angiogenesis in diabetic foot ulcer wound healing by regulating miR-96-5p.

Yang M, Gu Y Ir J Med Sci. 2023; 193(1):241-247.

PMID: 37515685 DOI: 10.1007/s11845-023-03471-x.


References
1.
Feng L, He M, Rao M, Diao J, Zhu Y . Long noncoding RNA DLEU1 aggravates glioma progression via the miR-421/MEF2D axis. Onco Targets Ther. 2019; 12:5405-5414. PMC: 6625645. DOI: 10.2147/OTT.S207542. View

2.
Li Y, Shi B, Dong F, Zhu X, Liu B, Liu Y . Long Non-coding RNA DLEU1 Promotes Cell Proliferation, Invasion, and Confers Cisplatin Resistance in Bladder Cancer by Regulating the miR-99b/HS3ST3B1 Axis. Front Genet. 2019; 10:280. PMC: 6449426. DOI: 10.3389/fgene.2019.00280. View

3.
Zhu Y, Jiang D . LncRNA PART1 modulates chondrocyte proliferation, apoptosis, and extracellular matrix degradation in osteoarthritis via regulating miR-373-3p/SOX4 axis. Eur Rev Med Pharmacol Sci. 2019; 23(19):8175-8185. DOI: 10.26355/eurrev_201910_19124. View

4.
Zhang J, Yin M, Peng G, Zhao Y . CRNDE: An important oncogenic long non-coding RNA in human cancers. Cell Prolif. 2018; 51(3):e12440. PMC: 6528921. DOI: 10.1111/cpr.12440. View

5.
Liu C, Tian X, Zhang J, Jiang L . Long Non-coding RNA DLEU1 Promotes Proliferation and Invasion by Interacting With miR-381 and Enhancing HOXA13 Expression in Cervical Cancer. Front Genet. 2018; 9:629. PMC: 6292861. DOI: 10.3389/fgene.2018.00629. View